spacer
home > pmps > summer 2007 > cold chain control
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cold Chain Control

Increasing legislation surrounding the cold chain storage and shipping of pharmaceuticals means that manufacturers and suppliers need to be more diligent than ever. Geraint Thomas of Laminar Medica assesses the latest generation of temperature-controlled packaging solutions

With pharmaceuticals and related products being distributed over increasingly long distances and through extreme temperature zones, the benefits of sophisticated temperature-controlled packaging solutions have become clear to drug manufacturers and suppliers. Shipments that reach temperatures outside of their acceptable limits often need to be recalled, leading to considerable losses and irreparable damage to valuable client relationships and the distributor’s reputation. In addition to enabling these risks to be minimised, the latest temperature controlled packaging solutions are helping pharmaceutical companies to comply with the growing amount of regulations and legislation now being introduced to ensure the safety and security of the storage and distribution of temperature sensitive drugs.

NEW REGULATIONS

A number of regulations and guidelines relating to the cold chain distribution of pharmaceuticals can now be found in pharmacopoeia and other publications such as The Guide to Good Storage Practice for Pharmaceuticals and The Guidelines on Good Distribution Practice (GDP) of Medicinal Products. These documents contain information on the latest legislation relating to the shipping of temperature-sensitive drugs, detailing the need for effective and standardised packaging and labelling for products, traceable and efficient dispatch processes, and the use of temperature recording devices to determine accurately whether a package has stayed within its acceptable temperature parameters.

According to documents produced by the European Medicines Evaluation Agency (EMEA), it is essential for the safe and secure distribution of pharmaceuticals that subjective terms such as ‘ambient conditions’, ‘room temperature’ and ‘cold’ in product storage and distribution guidelines are replaced with more accurate instructions relating to the acceptable conditions for drugs, and how to act should this environment not be maintained. For a more focused and regulated approach to storing and transporting drugs to be achieved, new and more sophisticated distribution systems are required to ensure that these tighter controls can be maintained.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Geraint Thomas graduated from Brunel University in 1996 with a BSc (first class honours) in Industrial Product Design. After working as a Board Game Engineer for Hasbro toys, he joined Laminar Medica in 1998 as a Packaging Development Technologist with responsibility for packaging solutions and qualification packages for insulated shipper design. Now employed as Technical Director, Geraint has been instrumental in realising Laminar Medica’s development programme, including the expansion of the company’s qualification laboratory and R&D facility.
spacer
Geraint Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Considerations for Choosing the Right Wearable Drug Delivery System

West Pharmaceutical Services, Inc.

For patients with chronic conditions, the use of injectable biologic therapies is on the rise. Biologics, while providing considerable therapeutic benefit, can also present several challenges for both drug manufacturers and patients. In particular, many biologics are highly viscous and others require large doses to be injected slowly over time. This can make it difficult to deliver a consistent dose every time, potentially impacting medication adherence.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement